2 February 2023
Luye Life Sciences Group Receives “Leading Enterprise. China High-Quality Development Pharmaceutical Companies” and “Brand Achievement” Awards
On 19th Feb, the 34th National Pharmaceutical Economy Information Conference, hosted by the Southern Institute of Pharmaceutical Economics under the National Medical Products Administration and hosted by Pharmaceutical Economics Daily, kicked off in Zhuhai. At the meeting, “Head Strength · High-quality Development Achievement Award of Chinese Medicine” was released, and Luye Life Sciences Group was selected as “high-quality development Achievement Enterprise of Chinese Medicine”.
Luye Pharma’s first-class innovative drug Ruoxinlin ® was rated as “Chinese Pharmaceutical high-quality development achievement brand”.
